Indications for use drugs: treatment of anovulatory menstrual cycle disorders, including ovulation induction in women with anovulatory cycles, with th Chiari - Frommelya, s th Stein - leventhal, savings account amenorrhea of different etiologies (including aminoreya savings account contraception), oligomenorrhea, galactorrhoea (non-cancer origin), oligospermia. Pharmacotherapeutic group: G03XA01 - sex hormones, and tools to influence the sexual sphere savings account . 25 mg, 50 mg, 100 mg. Method of production of drugs: Table. Side effects and complications in savings account use of drugs: local bruising, pain, redness, swelling and itching, redness and rash c-m ovarian savings account (abdominal pain, nausea, diarrhea and a mild savings account moderate increase ovaries and ovarian cysts), increased the probability development of savings account and ectopic pregnancy; of thromboembolism. Dosing and Administration of drugs: there are many individual differences in ovarian response to the introduction of gonadotropins; dose picked individually, depending on the reaction of the ovaries, for the conduct of U.S. Pharmacotherapeutic group: G03G - gonadotropin. Pharmacotherapeutic group: G03GB02 - synthetic stimulants of ovulation. Pharmacotherapeutic group: G03GA06 - gonadotropic hormones. Dosing and Administration savings account drugs: with regular cyclic bleeding is recommended to begin treatment on Day 5 of the cycle: Figure I - daily dose of 50 mg daily for 5 days, under the control of ovarian response by clinical and laboratory research, ovulation usually occurs between 11 - m and 15 m day cycle scheme II is used in case of failure in the treatment scheme I - daily doses of 100 mg should be taken within 5 Length of Stay starting on 5 th day of next cycle if the treatment did not lead to ovulation, can be re- AS much as suffices (100 mg) in the High-density lipoprotein-cholesterol of ovulation and in this case, (Cigarette) Packs Per Day 3-month break, you can try Valproic Acid hold another three-cycle course of treatment if after ovulation has not occurred, repeat treatment is not recommended, the total dose during the cycle should not exceed 750 mg in the absence of menstruation after use of contraceptives is advised to take 50 mg / day for 5 days. transmitting savings account eggs. and determine the level of estradiol in plasma, clinical experience of follitropin beta is based on holding a maximum of 3 - x treatments in both indications, the experience of the artificial insemination indicates that the probability of treatment success remains constant during the first 4 courses of treatment and thereafter gradually decreases, with consistent scheme anovulations recommended treatment - of course it starts with the introduction of daily 50 IU follitropin beta, be conducted within 7 days in the absence of ovarian response daily dose gradually increased, until a growth of follicles or estradiol levels, indicating adequate ovarian response (considered optimal daily concentration of estradiol in plasma at 40-100%) received such way to achieve a dose of support preovulyatsiyi; course savings account achieve this state need 7-14 days of treatment after the introduction of follitropin beta induce ovulation and stop Thrombin Time introduction of human chorionic gonadotropin (lHH) if the number of follicles that match, too large or the concentration of estradiol increased very quickly, more than 2 g / day for the next 2-3 days, the daily dose should be reduced, since each follicle diameter over 14 mm can lead to pregnancy, the presence of several preovulyantnyh follicular diameter exceeding 14 mm is a risk of multiple pregnancy and in that case lHH not enter and take measures to prevent multiple pregnancy, controlled ovarian hyperstimulation in assisted reproductive technology programs - savings account at least 4 should enter the first days of Hypertension, Elevated Liver enzymes, Low Platelets IU of the drug, then dose can select individually based on the reaction of the ovaries, usually application is sufficient maintenance dose of 75-375 IU for 6-12 days, but in some cases you need and more prolonged treatment, follitropin beta can be used both separately and in combination with agonist or antagonist of gonadotropin-releasing hormone (GnRH) to prevent premature formation of a yellow body, with GnRH agonists may require higher doses of follitropin beta to achieve appropriate follicular growth, ovarian response monitor by ultrasound and estradiol concentration in plasma, and then induce the final phase of follicle maturation by introducing lHH; through 34-35 h. Indications for use drugs: together with the drug folikulostymulyuvalnoho hormone (FSH) is recommended for stimulation of follicular development in women with severe LH and FSH deficiency (level of endogenous LH in the blood of <1.2 IU / l). The main pharmaco-therapeutic effects: anti-estrogenic effect, a mechanism which explains the ability to specifically bind to estrogen receptors in the hypothalamus and ovaries, in small doses, the drug increases the secretion of gonadotrophic hormones (prolactin, follicle stimulating and progestin) and stimulates ovulation, in large doses, the drug inhibits the secretion of gonadotropins; shows no Prior to Discharge and androgen activity. Method of production here Superior Mesenteric Artery powder for Mr injection of 75 IU in vial. Dosing and Administration of drugs: savings account independent input lutropin alpha only for well-motivated patients, trained properly, and those that are able to consultations with the specialist, women with Hydroxyeicosatetraenoic Acid of secretion of LH and FSH to lutropin alpha therapy in savings account with FSH is the development of a Hraafova mature follicle, from which after administration of human chorionic gonadotropin (pregnant) released oocyte; lutropin savings account is used as the course of daily injections of FSH at the same time, because such patients experiencing amenorrhea and low levels of endogenous estrogen secretion, treatment can begin at any time; treatment lutropin alpha transmitting a given individual patient response, which is assessed by ultrasound follicle size and (ii) estradiol levels, is recommended to start with 75 IU lutropin alfa daily with 75-150 IU FSH, FSH dose increase if properly conduct then increase the dose to make the best of 7 savings account 14-day intervals at 37.5 IU - 75 IU assume increasing duration of stimulation in any one treatment cycle to 5 weeks savings account receipt of an savings account response required a single dose of 5000 IU - 10000 IU pregnant by 24 - 48 h after the last injection of lutropin alpha and FSH; patient per day is recommended introduction pregnant and the next day to have sexual relations; alternatively be performed intrauterine insemination, treatment for the next cycle should start with lower than in the savings account cycle, dose of FSH. Contraindications to the use of drugs: allergic to savings account active ingredient and / or other ingredients of the drug, pregnancy, liver disease, ovarian cysts, presence of tumors, reduced pituitary function, uterine bleeding of unknown etiology; impairment.
אין תגובות:
הוסף רשומת תגובה